MONTARA THERAPEUTICS, INC.

Profile

Company Names

MONTARA THERAPEUTICS, INC.

Addresses

135 MISSISSIPPI STREET, SAN FRANCISCO, CA 94107

Phone Numbers

310-463-6172

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$28,000,006.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2025-02-26 
$19,999,995.00 
$19,999,995.00 
$0.00 
Equity 
1
2024-01-05 
$8,000,011.00 
$17,000,022.00 
$9,000,011.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RANDALL 
 
CHIN 
EXECUTIVE OFFICER
MONTARA THERAPEUTICS, INC.
NICHOLAS 
 
HERTZ 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
MITOKININ, INC.   |  MONTARA THERAPEUTICS, INC.
ZACHARY 
 
HILL 
EXECUTIVE OFFICER
SOTERIA BIOTHERAPEUTICS, INC.   |  HORSETAIL TECHNOLOGIES, LLC   |  MONTARA THERAPEUTICS, INC.
DIRK 
 
LANGDORF 
DIRECTOR
MONTARA THERAPEUTICS, INC.
MAX 
 
LEBOVITZ 
EXECUTIVE OFFICER
MONTARA THERAPEUTICS, INC.
RISHI 
 
RAKHIT 
EXECUTIVE OFFICER
MONTARA THERAPEUTICS, INC.
SETH 
 
STRATTON 
DIRECTOR
MONTARA THERAPEUTICS, INC.
TROY 
 
WILSON 
DIRECTOR
INTELLIKINE, INC.   |  CENTROSE LLC   |  ARAXES PHARMA, LLC   |  AVIDITY NANOMEDICINES LLC   |  ZOSANO PHARMA CORP   |  KURA ONCOLOGY, INC.   |  KURA ONCOLOGY, INC.   |  KURA OPERATIONS, INC.   |  AVIDITY BIOSCIENCES, INC.   |  ABINTUS BIO, INC.   |  MONTARA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-03-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-02-26 
2024-01-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#